Literature DB >> 1847452

When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates.

E A Hurley1, S Agger, J A McNeil, J B Lawrence, A Calendar, G Lenoir, D A Thorley-Lawson.   

Abstract

In this study we used Gardella gel analysis of intact DNA, Southern blotting of digested DNA, and fluorescence in situ hybridization to provide complementary and unequivocal information on the state of the Epstein-Barr virus (EBV) genome in persistently infected cells. The fluorescence in situ hybridization technique allowed us to directly visualize both integrated and episomal EBV DNA at the single-cell level. We show here that circularization of the EBV genome is rarely detected upon infecting activated normal B cells. The virus can persist upon infection of a different proliferating B-cell target, EBV-negative Burkitt's lymphoma tumor cell lines. Analysis of 16 such lines reveal again, that the virus infrequently persists as covalently closed episomes; rather, the virus preferentially persists by integrating into the host DNA (10 of 16 clones). The integrated virus is linear and usually intact, although 3 of 10 isolates have deletions from the left-hand end including the latent origin of replication. At the level of our analysis, no obvious relationship was seen between the integration sites. These studies provide, for the first time, a reproducible in vitro model system to study integration by EBV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847452      PMCID: PMC239896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.

Authors:  R J Murray; L S Young; A Calender; C D Gregory; M Rowe; G M Lenoir; A B Rickinson
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

Authors:  A Calender; M Billaud; J P Aubry; J Banchereau; M Vuillaume; G M Lenoir
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

Authors:  J L Yates; N Guan
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines.

Authors:  A Harris; B D Young; B E Griffin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

5.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

Authors:  D Wang; D Liebowitz; E Kieff
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

6.  Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.

Authors:  C D Gregory; T Tursz; C F Edwards; C Tetaud; M Talbot; B Caillou; A B Rickinson; M Lipinski
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

7.  Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo.

Authors:  C Kaschka-Dierich; A Adams; T Lindahl; G W Bornkamm; G Bjursell; G Klein; B C Giovanella; S Singh
Journal:  Nature       Date:  1976-03-25       Impact factor: 49.962

8.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

9.  Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

Authors:  C M Rooney; C D Gregory; M Rowe; S Finerty; C Edwards; H Rupani; A B Rickinson
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

10.  B cell activation and the establishment of Epstein-Barr virus latency.

Authors:  E A Hurley; D A Thorley-Lawson
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  40 in total

1.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.

Authors:  C N Yandava; S H Speck
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.

Authors:  A Marchini; R Longnecker; E Kieff
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Epstein-Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line RGN1.

Authors:  G Gualandi; E Santolini; E Calef
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA.

Authors:  E A Hurley; L D Klaman; S Agger; J B Lawrence; D A Thorley-Lawson
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.

Authors:  David J Hughes; Carol A Dickerson; Marie S Shaner; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

8.  Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.

Authors:  L L Decker; L D Klaman; D A Thorley-Lawson
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome.

Authors:  Clinton R Paden; J Craig Forrest; Nathaniel J Moorman; Samuel H Speck
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

10.  Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.

Authors:  L J Strobl; H Höfelmayr; G Marschall; M Brielmeier; G W Bornkamm; U Zimber-Strobl
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.